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Background: Mean luminal area (MLA) ≤4.0mm2 by intravascular ultrasound (IVUS) in angiographically intermediate lesions is often used as a 
criterion for performing PCI.
Methods: 697 patients with ACS underwent 3-vessel quantitative coronary angiography, gray-scale and radiofrequency IVUS immediately following 
successful PCI of their culprit lesion(s) (CL). IVUS MLA, plaque burden (PB) and presence of thin-cap fibroatheroma (TCFA) were evaluated. Major 
adverse cardiovascular events (MACE; cardiac death, arrest, myocardial infarction (MI), or rehospitalization for unstable or progressive angina) were 
adjudicated at a median follow-up of 3.4 years to originally treated CLs or untreated non-CLs (NCLs).
Results: The mean age in PROSPECT was 58.1 years, 24% were women and 17.1% had diabetes. There were 541 and 2,339 NCL with MLA 
≤4.0mm2 and >4.0mm2, respectively. MACE arose significantly more frequently from NCLs with baseline MLA ≤4.0mm2 than >4.0 mm2 (5.3% vs. 
1.1%, unadjusted HR 5.00, 95% CI 2.94-8.51, p<0.001). MACE arising from NCLs with MLA ≤ 4.0mm2 was infrequent unless the NCL was also a 
TCFA or had PB >70% (Figure). MACE arising from NCL with MLA ≤4.0mm2 consisted of rehospitalization for progressive or unstable angina, with no 
cases of cardiac death, arrest or MI.
Conclusion: In patients with ACS, long-term MACE attributable to NCLs is more dependent on the degree of PB and plaque composition (TCFA) 
rather than MLA. Future trials of deferral vs. treatment on the basis of these criteria are warranted.
 
